Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Common Equity (2017 - 2026)

Equillium (EQ) posted quarterly Common Equity of $59.5 million for Q1 2026, up 462.37% year-over-year from $10.6 million in Q1 2025, and up 108.02% quarter-over-quarter from $28.6 million in Q4 2025.

Analysis

Equillium (EQ) Common Equity (2017 - 2026) Analysis & Trends

Equillium (EQ) has reported Common Equity for 10 consecutive years, with $59.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Common Equity rose 462.37% year-over-year to $59.5 million; the TTM figure through Mar 2026 stood at $59.5 million (up 462.37% YoY), while the FY2025 annual figure was $28.6 million, up 50.03% from the prior year.
  • Common Equity climbed to $59.5 million in Q1 2026 per EQ's latest filing, from $28.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $59.5 million in Q1 2026 and bottomed at $5.1 million in Q2 2025.
  • Historically, Common Equity has averaged $28.0 million across 5 years, with a median of $27.0 million in 2023.
  • Annual changes were most pronounced in 2025 — Common Equity tumbled 77.46% — and 2026, when it surged 462.37%.
  • Equillium's Common Equity stood at $31.9 million in 2022, then decreased by 29.33% to $22.6 million in 2023, then dropped by 15.56% to $19.1 million in 2024, then jumped by 50.03% to $28.6 million in 2025, then jumped by 108.02% to $59.5 million in 2026.
  • Business Quant data shows EQ's Common Equity at $59.5 million in Q1 2026, $28.6 million in Q4 2025, and $30.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 Equillium 249.33 Mn 249.33 Mn - 56.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.02 Mn
Mar 31, 2026 59.49 Mn
Dec 31, 2025 28.60 Mn
Sep 30, 2025 30.94 Mn
Jun 30, 2025 5.06 Mn
Mar 31, 2025 10.58 Mn
Dec 31, 2024 19.06 Mn
Sep 30, 2024 23.18 Mn
Jun 30, 2024 22.43 Mn
Mar 31, 2024 21.09 Mn
Dec 31, 2023 22.57 Mn
Sep 30, 2023 24.11 Mn
Jun 30, 2023 26.98 Mn
Mar 31, 2023 29.27 Mn
Dec 31, 2022 31.94 Mn
Sep 30, 2022 28.16 Mn
Jun 30, 2022 40.27 Mn
Mar 31, 2022 52.63 Mn
Dec 31, 2021 66.51 Mn
Sep 30, 2021 75.80 Mn